Arterial spin labeling (ASL) MRI allows the quantification of tissue perfusion without administration of exogenous contrast agents. Patients with reduced renal function or other contraindications to Gadolinium-based contrast media may benefit from the non-invasive monitoring of tissue microcirculation. So far, only few studies have investigated the sensitivity, the specificity and the reliability of the ASL techniques for the assessment of renal perfusion. Moreover, only little is known about the interplay between ASL markers of perfusion and functional renal filtration parameters. In this editorial, we discuss the main technical issues related to the quantification of renal perfusion by ASL and, in particular, the latest results in patients with kidney disorders.

1.
Calamante F: Arterial input function in perfusion MRI: a comprehensive review. Prog Nucl Magn Reson Spectrosc 2013;74:1-32.
2.
Todd DJ, Kay J: Gadolinium-induced fibrosis. Annu Rev Med 2016;67:273-291.
3.
Detre JA, Leigh JS, Williams DS, Koretsky AP: Perfusion imaging. Magn Reson Med 1992;23:37-45.
4.
Williams DS, Detre JA, Leigh JS, Koretsky AP: Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 1992;89:212-216.
5.
Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR: A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40:383-396.
6.
Atlas SW: Magnetic Resonance Imaging of the Brain and Spine, ed 4. Philadelphia, Lippincott Williams & Wilkins, 2009.
7.
Martirosian P, Klose U, Mader I, Schick F: Fair true-FISP perfusion imaging of the kidneys. Magn Reson Med 2004;51:353-361.
8.
Ebrahimi B, Gloviczki M, Woollard JR, Crane JA, Textor SC, Lerman LO: Compartmental analysis of renal BOLD MRI data: introduction and validation. Invest Radiol 2012;47:175-182.
9.
Yongbi MN, Fera F, Yang Y, Frank JA, Duyn JH: Pulsed arterial spin labeling: comparison of multisection baseline and functional MR imaging perfusion signal at 1.5 and 3.0 t: initial results in six subjects. Radiology 2002;222:569-575.
10.
Wang J, Zhang Y, Wolf RL, Roc AC, Alsop DC, Detre JA: Amplitude-modulated continuous arterial spin-labeling 3.0-t perfusion MR imaging with a single coil: feasibility study. Radiology 2005;235:218-228.
11.
Dai W, Garcia D, de Bazelaire C, Alsop DC: Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60:1488-1497.
12.
Prevost VH, Girard OM, Callot V, Cozzone PJ, Duhamel G: Fast imaging strategies for mouse kidney perfusion measurement with pseudocontinuous arterial spin labeling (pCASL) at ultra high magnetic field (11.75 tesla). J Magn Reson Imaging 2015;42:999-1008.
13.
Robson PM, Madhuranthakam AJ, Smith MP, Sun MR, Dai W, Rofsky NM, Pedrosa I, Alsop DC: Volumetric arterial spin-labeled perfusion imaging of the kidneys with a three-dimensional fast spin echo acquisition. Acad Radiol 2016;23:144-154.
14.
Alsop DC, Detre JA: Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996;16:1236-1249.
15.
Edelman RR, Siewert B, Darby DG, Thangaraj V, Nobre AC, Mesulam MM, Warach S: Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency. Radiology 1994;192:513-520.
16.
Shimizu K, Kosaka N, Fujiwara Y, Matsuda T, Yamamoto T, Tsuchida T, Tsuchiyama K, Oyama N, Kimura H: Arterial transit time-corrected renal blood flow measurement with pulsed continuous arterial spin labeling MR imaging. Magn Reson Med Sci 2016, Epub ahead of print.
17.
Ye FQ, Mattay VS, Jezzard P, Frank JA, Weinberger DR, McLaughlin AC: Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med 1997;37:226-235.
18.
Parkes LM, Tofts PS: Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling: accounting for capillary water permeability. Magn Reson Med 2002;48:27-41.
19.
Kiefer C, Schroth G, Gralla J, Diehm N, Baumgartner I, Husmann M: A feasibility study on model-based evaluation of kidney perfusion measured by means of FAIR prepared true-FISP arterial spin labeling (ASL) on a 3-T MR scanner. Acad Radiol 2009;16:79-87.
20.
Detre JA, Rao H, Wang DJ, Chen YF, Wang Z: Applications of arterial spin labeled MRI in the brain. J Magn Reson Imaging 2012;35:1026-1037.
21.
van Heeswijk RB, Bonanno G, Coppo S, Coristine A, Kober T, Stuber M: Motion compensation strategies in magnetic resonance imaging. Crit Rev Biomed Eng 2012;40:99-119.
22.
Robson PM, Madhuranthakam AJ, Dai W, Pedrosa I, Rofsky NM, Alsop DC: Strategies for reducing respiratory motion artifacts in renal perfusion imaging with arterial spin labeling. Magn Reson Med 2009;61:1374-1387.
23.
Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P: SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-962.
24.
Boss A, Martirosian P, Klose U, Nägele T, Claussen CD, Schick F: Fair-trueFISP imaging of cerebral perfusion in areas of high magnetic susceptibility differences at 1.5 and 3 tesla. J Magn Reson Imaging 2007;25:924-931.
25.
Gao Y, Goodnough CL, Erokwu BO, Farr GW, Darrah R, Lu L, Dell KM, Yu X, Flask CA: Arterial spin labeling-fast imaging with steady-state free precession (ASL-FISP): a rapid and quantitative perfusion technique for high-field MRI. NMR Biomed 2014;27:996-1004.
26.
Rajendran R, Lew SK, Yong CX, Tan J, Wang DJ, Chuang KH: Quantitative mouse renal perfusion using arterial spin labeling. NMR Biomed 2013;26:1225-1232.
27.
Huang SY, Seethamraju RT, Patel P, Hahn PF, Kirsch JE, Guimaraes AR: Body MR imaging: Artifacts, k-space, and solutions. Radiographics 2015;35:1439-1460.
28.
Boss A, Martirosian P, Graf H, Claussen CD, Schlemmer HP, Schick F: High resolution MR perfusion imaging of the kidneys at 3 tesla without administration of contrast media. RoFo 2005;177:1625-1630.
29.
Cutajar M, Thomas DL, Hales PW, Banks T, Clark CA, Gordon I: Comparison of ASL and DCE MRI for the non-invasive measurement of renal blood flow: quantification and reproducibility. Eur Radiol 2014;24:1300-1308.
30.
He X, Aghayev A, Gumus S, Ty Bae K: Estimation of single-kidney glomerular filtration rate without exogenous contrast agent. Magn Reson Med 2014;71:257-266.
31.
Kistner I, Ott C, Jumar A, Friedrich S, Grosso R, Siegl C, Schmieder RE, Janka R: 1D.09: applicability of measurement of renal perfusion using 1.5 tesla MRI arterial spin labelling. J Hypertens 2015;33(suppl 1):e17.
32.
Cutajar M, Thomas DL, Banks T, Clark CA, Golay X, Gordon I: Repeatability of renal arterial spin labelling MRI in healthy subjects. MAGMA 2012;25:145-153.
33.
Gillis KA, McComb C, Foster JE, Taylor AH, Patel RK, Morris ST, Jardine AG, Schneider MP, Roditi GH, Delles C, Mark PB: Inter-study reproducibility of arterial spin labelling magnetic resonance imaging for measurement of renal perfusion in healthy volunteers at 3 tesla. BMC Nephrol 2014;15:23.
34.
Hammon M, Janka R, Siegl C, Seuss H, Grosso R, Martirosian P, Schmieder RE, Uder M, Kistner I: Reproducibility of kidney perfusion measurements with arterial spin labeling at 1.5 tesla MRI combined with semiautomatic segmentation for differential cortical and medullary assessment. Medicine (Baltimore) 2016;95:e3083.
35.
Winter JD, St Lawrence KS, Cheng HL: Quantification of renal perfusion: comparison of arterial spin labeling and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2011;34:608-615.
36.
Artz NS, Wentland AL, Sadowski EA, Djamali A, Grist TM, Seo S, Fain SB: Comparing kidney perfusion using noncontrast arterial spin labeling MRI and microsphere methods in an interventional swine model. Invest Radiol 2011;46:124-131.
37.
Tan H, Thacker J, Franklin T, Prasad PV: Sensitivity of arterial spin labeling perfusion MRI to pharmacologically induced perfusion changes in rat kidneys. J Magn Reson Imaging 2015;41:1124-1128.
38.
Wang J, Zhang Y, Yang X, Wang X, Zhang J, Fang J, Jiang X: Hemodynamic effects of furosemide on renal perfusion as evaluated by ASL-MRI. Acad Radiol 2012;19:1194-1200.
39.
Barry R, James MT: Guidelines for classification of acute kidney diseases and disorders. Nephron 2015;131:221-226.
40.
Gillis KA, McComb C, Patel RK, Stevens KK, Schneider MP, Radjenovic A, Morris ST, Roditi GH, Delles C, Mark PB: Non-contrast renal magnetic resonance imaging to assess perfusion and corticomedullary differentiation in health and chronic kidney disease. Nephron 2016;133:183-192.
41.
Rossi C, Artunc F, Martirosian P, Schlemmer HP, Schick F, Boss A: Histogram analysis of renal arterial spin labeling perfusion data reveals differences between volunteers and patients with mild chronic kidney disease. Invest Radiol 2012;47:490-496.
42.
Ritt M, Janka R, Schneider MP, Martirosian P, Hornegger J, Bautz W, Uder M, Schmieder RE: Measurement of kidney perfusion by magnetic resonance imaging: comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrol Dial Transplant 2010;25:1126-1133.
43.
de Bazelaire C, Alsop DC, George D, Pedrosa I, Wang Y, Michaelson MD, Rofsky NM: Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. Clin Cancer Res 2008;14:5548-5554.
44.
Lanzman RS, Robson PM, Sun MR, Patel AD, Mentore K, Wagner AA, Genega EM, Rofsky NM, Alsop DC, Pedrosa I: Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings. Radiology 2012;265:799-808.
45.
Lanzman RS, Wittsack HJ, Martirosian P, Zgoura P, Bilk P, Kröpil P, Schick F, Voiculescu A, Blondin D: Quantification of renal allograft perfusion using arterial spin labeling MRI: initial results. Eur Radiol 2010;20:1485-1491.
46.
Yuan Q, Kapur P, Zhang Y, Xi Y, Carvo I, Signoretti S, Dimitrov IE, Cadeddu JA, Margulis V, Brugarolas J, Madhuranthakam AJ, Pedrosa I: Intratumor heterogeneity of perfusion and diffusion in clear-cell renal cell carcinoma: correlation with tumor cellularity. Clin Genitourin Cancer 2016;pii:S1558-7673(16)30097-0.
47.
Zhang Y, Kapur P, Yuan Q, Xi Y, Carvo I, Signoretti S, Dimitrov I, Cadeddu JA, Margulis V, Muradyan N, Brugarolas J, Madhuranthakam AJ, Pedrosa I: Tumor vascularity in renal masses: correlation of arterial spin-labeled and dynamic contrast-enhanced magnetic resonance imaging assessments. Clin Genitourin Cancer 2016;14:e25-e36.
48.
Rajendran R, Huang W, Tang AM, Liang JM, Choo S, Reese T, Hentze H, van Boxtel S, Cliffe A, Rogers K, Henry B, Chuang KH: Early detection of antiangiogenic treatment responses in a mouse xenograft tumor model using quantitative perfusion MRI. Cancer Med 2014;3:47-60.
49.
Schor-Bardach R, Alsop DC, Pedrosa I, Solazzo SA, Wang X, Marquis RP, Atkins MB, Regan M, Signoretti S, Lenkinski RE, Goldberg SN: Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model? Radiology 2009;251:731-742.
50.
Boss A, Martirosian P, Schraml C, Clasen S, Fenchel M, Anastasiadis A, Claussen CD, Pereira PL, Schick F: Morphological, contrast-enhanced and spin labeling perfusion imaging for monitoring of relapse after RF ablation of renal cell carcinomas. Eur Radiol 2006;16:1226-1236.
51.
Artz NS, Sadowski EA, Wentland AL, Djamali A, Grist TM, Seo S, Fain SB: Reproducibility of renal perfusion MR imaging in native and transplanted kidneys using non-contrast arterial spin labeling. J Magn Reson Imaging 2011;33:1414-1421.
52.
Heusch P, Wittsack HJ, Blondin D, Ljimani A, Nguyen-Quang M, Martirosian P, Zenginli H, Bilk P, Kröpil P, Heusner TA, Antoch G, Lanzman RS: Functional evaluation of transplanted kidneys using arterial spin labeling MRI. J Magn Reson Imaging 2014;40:84-89.
53.
Niles DJ, Artz NS, Djamali A, Sadowski EA, Grist TM, Fain SB: Longitudinal assessment of renal perfusion and oxygenation in transplant donor-recipient pairs using arterial spin labeling and blood oxygen level-dependent magnetic resonance imaging. Invest Radiol 2016;51:113-120.
54.
Ren T, Wen CL, Chen LH, Xie SS, Cheng Y, Fu YX, Oesingmann N, de Oliveira A, Zuo PL, Yin JZ, Xia S, Shen W: Evaluation of renal allografts function early after transplantation using intravoxel incoherent motion and arterial spin labeling MRI. Magn Reson Imaging 2016;34:908-914.
55.
Cutajar M, Hilton R, Olsburgh J, Marks SD, Thomas DL, Banks T, Clark CA, Gordon I: Renal blood flow using arterial spin labelling MRI and calculated filtration fraction in healthy adult kidney donors pre-nephrectomy and post-nephrectomy. Eur Radiol 2015;25:2390-2396.
56.
Rabe M, Schaefer F: Non-transgenic mouse models of kidney disease. Nephron 2016;133:53-61.
57.
Hueper K, Gutberlet M, Rong S, Hartung D, Mengel M, Lu X, Haller H, Wacker F, Meier M, Gueler F: Acute kidney injury: arterial spin labeling to monitor renal perfusion impairment in mice-comparison with histopathologic results and renal function. Radiology 2014;270:117-124.
58.
Prasad PV: Evaluation of intra-renal oxygenation by BOLD MRI. Nephron Clin Pract 2006;103:c58-c65.
59.
Chen WB, Liang L, Zhang B, Liu CL, Liu HJ, Luo HY, Zeng QX, Liang CH, Liu GS, Zhang SX: To evaluate the damage of renal function in CIAKI rats at 3T: using ASL and BOLD MRI. Biomed Res Int 2015;2015:593060.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.